Literature DB >> 18462007

Selective inhibition of aromatase by a dihydroisocoumarin from Xyris pterygoblephara.

Denise C Endringer1, Keller G Guimarães, Tamara P Kondratyuk, John M Pezzuto, Fernão C Braga.   

Abstract

Aromatase is a well-established target for the chemoprevention of breast cancer. The dihydroisocoumarin (3 R,4 R)-(-)-6-methoxy-1-oxo-3-pentyl-3,4-dihydro-1 H-isochromen-4-yl acetate (1) (IC 50 = 1.6 +/- 0.1 microM), isolated from aerial parts of Xyris pterygoblephara, showed aromatase inhibitory activity. The specificity of 1 was evaluated by inhibition assays with cytochrome P450 enzymes. CYP1A1 was inhibited modestly (IC 50 = 38.0 +/- 2.0 microM), while CYP2C8 and CYP3A4 enzymes were not affected. Dihydroisocoumarin 1 showed weak antiproliferative activity against MCF-7 (IC 50 = 66.9 +/- 2.3 microM) and LNCaP (IC 50 = 57.5 +/- 2.0 microM) cells and was inactive against LU-1 and HepG2 cells in culture. These results demonstrate the potential of dihydroisocoumarin 1 to serve as a selective aromatase inhibitor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18462007      PMCID: PMC2562161          DOI: 10.1021/np800098f

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  29 in total

1.  Biochemical and biological characterization of a novel anti-aromatase coumarin derivative.

Authors:  Shiuan Chen; Michael Cho; Kimberly Karlsberg; Dujin Zhou; Yate-Ching Yuan
Journal:  J Biol Chem       Date:  2004-09-08       Impact factor: 5.157

Review 2.  Aromatase inhibitors: current indications and future prospects for treatment of postmenopausal breast cancer.

Authors:  Amit Arora; Jane F Potter
Journal:  J Am Geriatr Soc       Date:  2004-04       Impact factor: 5.562

3.  Design, synthesis, and 3D QSAR of novel potent and selective aromatase inhibitors.

Authors:  Francesco Leonetti; Angelo Favia; Angela Rao; Rosaria Aliano; Anja Paluszcak; Rolf W Hartmann; Angelo Carotti
Journal:  J Med Chem       Date:  2004-12-30       Impact factor: 7.446

Review 4.  Drug metabolism and variability among patients in drug response.

Authors:  Grant R Wilkinson
Journal:  N Engl J Med       Date:  2005-05-26       Impact factor: 91.245

5.  Distribution of composite CYP1A1 genotypes in Africans, African-Americans and Caucasians.

Authors:  S J Garte; J Trachman; F Crofts; P Toniolo; J Buxbaum; S Bayo; E Taioli
Journal:  Hum Hered       Date:  1996 May-Jun       Impact factor: 0.444

6.  Inhibition of human cytochrome CYP 1 enzymes by flavonoids of St. John's wort.

Authors:  Amit Chaudhary; Kristine L Willett
Journal:  Toxicology       Date:  2005-11-04       Impact factor: 4.221

7.  The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects.

Authors:  Carmen Martínez; Elena García-Martín; Gerardo Blanco; Francisco J G Gamito; José M Ladero; José A G Agúndez
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

8.  Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.

Authors:  K Sonne-Hansen; A E Lykkesfeldt
Journal:  J Steroid Biochem Mol Biol       Date:  2005-01-27       Impact factor: 4.292

9.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

Review 10.  First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen?

Authors:  Z-W Wong; M J Ellis
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

View more
  5 in total

1.  Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives.

Authors:  Kevin Bonfield; Erica Amato; Tony Bankemper; Hannah Agard; Jeffrey Steller; James M Keeler; David Roy; Adam McCallum; Stefan Paula; Lili Ma
Journal:  Bioorg Med Chem       Date:  2012-02-27       Impact factor: 3.641

Review 2.  Natural compounds with aromatase inhibitory activity: an update.

Authors:  Marcy J Balunas; A Douglas Kinghorn
Journal:  Planta Med       Date:  2010-07-15       Impact factor: 3.352

3.  Synthesis of isocoumarins with different substituted patterns via Passerini-aldol sequence.

Authors:  Guan-Hua Ma; Bo Jiang; Xing-Jun Tu; Yi Ning; Shu-Jiang Tu; Guigen Li
Journal:  Org Lett       Date:  2014-08-20       Impact factor: 6.005

4.  Screening for compounds with aromatase inhibiting activities from Atractylodes macrocephala Koidz.

Authors:  Hai Jiang; Jing Shi; Yuanyuan Li
Journal:  Molecules       Date:  2011-04-14       Impact factor: 4.411

5.  Uncovering the Mechanisms of Chinese Herbal Medicine (MaZiRenWan) for Functional Constipation by Focused Network Pharmacology Approach.

Authors:  Tao Huang; Ziwan Ning; Dongdong Hu; Man Zhang; Ling Zhao; Chengyuan Lin; Linda L D Zhong; Zhijun Yang; Hongxi Xu; Zhaoxiang Bian
Journal:  Front Pharmacol       Date:  2018-03-26       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.